Replies to post #24320 on Ocata Therapeutics Inc fka OCAT

[louisa]

Good Morning, thanks and happy Wednesday, September 22, 2010. Smiling here. ~,o

[rocky301]

thanks rumit,

Nice to see some dollars coming in for research other than the normal dilutive financing. I believe todays PR rules out the "red blood IND" for second half of this year. I am still thinking the other IND for 2010 may be the following.
"In addition, ACT has an hemangioblast cell program in preclinical research for possible use of the cells to treat cardiovascular disease, stroke and cancer. ACT's research, published in Nature Methods, has demonstrated success in treating vascular indications such as heart attack and limb loss due to vascular damage. An IND for that program is expected to be filed in 2010. "
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=48105953

Announce 2nd cellular-based IND in area other than retinal program
(I think we can speculate that this is for red blood cells and/or platelets, per the Sept presentation)
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=54637750